Literature DB >> 19156448

[Multimodal pain therapy: principles and indications].

B Arnold1, T Brinkschmidt, H-R Casser, I Gralow, D Irnich, K Klimczyk, G Müller, B Nagel, M Pfingsten, M Schiltenwolf, R Sittl, W Söllner.   

Abstract

Multimodal pain therapy describes an integrated multidisciplinary treatment in small groups with a closely coordinated therapeutical approach. Somatic and psychotherapeutic procedures cooperate with physical and psychological training programs. For chronic pain syndromes with complex somatic, psychological and social consequences, a therapeutic intensity of at least 100 hours is recommended. Under these conditions multimodal pain therapy has proven to be more effective than other kinds of treatment. If monodisciplinary and/or outpatient therapies fail, health insurance holders have a legitimate claim to this form of therapy.Medical indications are given for patients with chronic pain syndromes, but also if there is an elevated risk of chronic pain in the early stadium of the disease and aiming at delaying the process of chronification. Relative contraindications are a lack of motivation for behavioural change, severe mental disorders or psychopathologies and addiction problems. The availability of multimodal pain treatment centers in Germany is currently insufficient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156448     DOI: 10.1007/s00482-008-0741-x

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  36 in total

1.  Comorbidity of low back pain: representative outcomes of a national health study in the Federal Republic of Germany.

Authors:  Sven Schneider; Sigrid M Mohnen; Marcus Schiltenwolf; Christoph Rau
Journal:  Eur J Pain       Date:  2006-06-21       Impact factor: 3.931

2.  Meta-analysis of psychological interventions for chronic low back pain.

Authors:  Benson M Hoffman; Rebecca K Papas; David K Chatkoff; Robert D Kerns
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

3.  The influence of the grade of chronicity on the outcome of multidisciplinary therapy for chronic low back pain.

Authors:  Matthias Buchner; Eva Neubauer; Anita Zahlten-Hinguranage; Marcus Schiltenwolf
Journal:  Spine (Phila Pa 1976)       Date:  2007-12-15       Impact factor: 3.468

4.  HKF-R 10 - screening for predicting chronicity in acute low back pain (LBP): a prospective clinical trial.

Authors:  Eva Neubauer; Astrid Junge; Peter Pirron; Hanne Seemann; Marcus Schiltenwolf
Journal:  Eur J Pain       Date:  2005-10-03       Impact factor: 3.931

5.  [Interventions for improvement of primary care in patients with low back pain: how effective are advice to primary care physicians on therapies and a multimodal therapy program arising out of cooperation of outpatient health care structures?].

Authors:  E Lang; S Kastner; K Liebig; B Neundörfer
Journal:  Schmerz       Date:  2002-02       Impact factor: 1.107

6.  Work stress and incidence of newly diagnosed fibromyalgia: prospective cohort study.

Authors:  Mika Kivimäki; Päivi Leino-Arjas; Marianna Virtanen; Marko Elovainio; Liisa Keltikangas-Järvinen; Sampsa Puttonen; Maarit Vartia; Eric Brunner; Jussi Vahtera
Journal:  J Psychosom Res       Date:  2004-11       Impact factor: 3.006

7.  [Comorbidity in patients with chronic low back pain].

Authors:  M Buchner; E Neubauer; A Barie; M Schiltenwolf
Journal:  Schmerz       Date:  2007-06       Impact factor: 1.107

8.  A 3-year follow-up of a multidisciplinary rehabilitation programme for back and neck pain.

Authors:  Irene B Jensen; Gunnar Bergström; Therese Ljungquist; Lennart Bodin
Journal:  Pain       Date:  2005-04-19       Impact factor: 6.961

9.  [Impact of readiness to change of the transtheoretical model (TTM) for the course of coping with chronic pain].

Authors:  J Rau; I Ehlebracht-König; F Petermann
Journal:  Schmerz       Date:  2007-11       Impact factor: 1.107

10.  Risk factors of chronicity in lumbar disc patients. A prospective investigation of biologic, psychologic, and social predictors of therapy outcome.

Authors:  M Hasenbring; G Marienfeld; D Kuhlendahl; D Soyka
Journal:  Spine (Phila Pa 1976)       Date:  1994-12-15       Impact factor: 3.468

View more
  65 in total

1.  [Health-related quality of life (SF-36) in chronic low back pain and comorbid depression].

Authors:  C Ahrens; M Schiltenwolf; H Wang
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

2.  [Effectiveness of intensive multimodal pain management programs].

Authors:  M Pfingsten; B Arnold; B Nagel; D Irnich
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

Review 3.  [Activating physiotherapy for chronic pain in elderly patients. Recommendations, barriers and resources].

Authors:  K Kuss; M Laekeman
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

Review 4.  [Multimodal pain therapy. Current situation].

Authors:  U Kaiser; R Sabatowski; S C Azad
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

Review 5.  [Recommendations on classification of German pain treatment services].

Authors:  R Sabatowski; C Maier; A Willweber-Strumpf; M Thomm; P Nilges; H Kayser; R Casser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

6.  [We must fundamentally change the care of chronic back pain patients!].

Authors:  L Weh
Journal:  Orthopade       Date:  2009-10       Impact factor: 1.087

7.  [Orthopedic specialists in an interdisciplinary setting. Multimodal therapy for chronic back pain].

Authors:  L Weh; U Marnitz
Journal:  Orthopade       Date:  2009-10       Impact factor: 1.087

8.  [Chronic knee pain and specific heat phobia. A case report].

Authors:  W Pepke; E Neubauer; M Schiltenwolf
Journal:  Schmerz       Date:  2013-02       Impact factor: 1.107

9.  [Intersectoral pain treatment. The Algesiologikum group].

Authors:  A-M Schneider; B Klasen; C Jennerwein; V E Amelung; R Thoma
Journal:  Schmerz       Date:  2013-04       Impact factor: 1.107

10.  [From GRIP to multimodal pain therapy. A concept asserts itself].

Authors:  J Hildebrandt; M Pfingsten
Journal:  Orthopade       Date:  2009-10       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.